INTRODUCTION
Immune infiltration is a fundamental component of solid tumors (1) , its involvement in cancer progression being documented by preclinical and clinical studies. The adaptive immune response plays an active role in controlling cancer growth and dissemination. In fact, T cell infiltration correlates to favorable prognosis in various common neoplastic diseases, including colo-rectal cancer (CRC) (2) (3) (4) (5) , thus emerging as a potential immune biomarker of outcome and promising therapeutic target. In CRC, tumor infiltrating lymphocytes (TILs) are associated to favorable prognosis (2-4, 6-8), independently by TNM stage (3, 6, 8) , or only in stage II CRC (4) . Surprisingly, despite the documented association between TILs and the clinical outcome, the dynamics of T cell recruitment and activation along CRC progression have not been fully elucidated.
Tertiary (or ectopic) lymphoid tissue (TLT) is a vascularized immune compartment that
forms at sites of exacerbated inflammatory reactions and is potentially involved in the promotion of adaptive immune responses (9, 10). Similarly to secondary lymphoid organs, the function of TLT is dependent on its structural organization, with B-cell follicles, T-cell areas and specialized haematic and lymphatic vessels, suggesting the possibility that it behaves as a functional immune site (11, 12) . TLT is found in the inflamed area of several autoimmune diseases (13) , chronic inflammatory conditions (14) (15) (16) and some tumor types (17) (18) (19) (20) (21) . In these clinical settings, TLT improves the 6 lymphoid tissue, a frequent manifestation of chronic inflammatory conditions, and infiltration of T cells with antitumor properties.
As in secondary lymphoid organs, the formation of TLT relies on few molecular mediators released by resident stromal cells, including members of the lymphotoxin family (30) and lymphorganogenic chemokines (CXCL13 and CCL21), responsible for lymphoid cell recruitment (30) (31) (32) (33) . During the process of adult lymphoid neogenesis, similar molecular mediators and cellular interactions induce formation of specialized vessels including high endothelial venules (HEV) and lymphatics, which support traffic of lymphocytes from the blood to lymphoid tissues and lymph nodes (34) . The presence of HEV in ectopic tissues indicates the possibility for naïve and central memory T lymphocytes to be recruited, thanks to their expression of L-selectin (CD62L) and its specific binding to PNAd, selectively expressed on HEV (35) . In fact, the formation of HEV has been suggested to mediate rapid recruitment of lymphocytes into chronically inflamed tissues, including some tumor tissues (36) .
In the present study, we investigated the contribution of TLT to CD3+ T cell infiltration in colo-rectal cancer. In a retrospective cohort study, we identified highly organized lymphocyte aggregates representing bona fide tertiary lymphoid tissue and we defined its prognostic relevance with respect to CD3+ T cell infiltration and demographics, clinical and histopathological variables and their interactions. In a preclinical model of colitis-associated CRC, we functionally addressed the question whether TLT is involved in the recruitment of T lymphocytes into colon cancer tissue.
MATERIALS AND METHODS
Patients. Tissue specimens from 351 stage II and III patients without any sign of metastatic disease at diagnosis who consecutively underwent radical surgical resection for pT3 or pT4 colorectal cancer (CRC), were expanded from the previous series (4) . Patients' demographics, clinical and histopathological data were available and obtained from the Institutional Intranet; please refer to Supplementary Table S1 for the list of the variables assessed. The absence of metastasis at diagnosis was assessed in all patients by combining histopathological findings, surgical records and perioperative imaging. To study the prediction of disease recurrences according to the state of immune infiltration, patients with pT1 or pT2 CRC, who have a very low risk of progression at diagnosis, and patients with perioperatively detected metastases were excluded. To exclude potential confounders in the study design, stage I patients were not enrolled in the cohort studied for their unlikely occurrence of disease recurrence, while stage IV CRC patients were not included because they are characterized by the presence of distant metastasis, which is an outcome event of our analysis. Patients who underwent neoadjuvant radiotherapy for rectal cancer were excluded from the study, because of the possibility of interference with the assessment of the local immune response. Chemotherapy treatment was administered and allocated by a nonrandom assignment according to adjuvant protocols in use at the time of Table S1 ). These variables, together with the median values of TLT and TIL IRA, were tested as predictors of patient's outcome. The outcome of patients who undergo radical resection of colorectal cancer is a variable affected by an event defined as any local tumor recurrences or any metachronous distant-organ metastases and named disease free Polymer kit (Biocare) followed. Diaminobenzidine tetrahydrochloride (DAB) (Dako) was used as chromogen. Nuclei were lightly counterstained with a freshly made haematoxylin solution (Medite).
Presence of fibrosis was assessed on 2 μm-thick sections stained for 20 min with 0.1% Sirius red in saturated picric acid (Sigma-Aldrich). The sections were further washed in water, mounted and analyzed under an optical microscopy. Microsatellite status was screened preliminarily for all cancers included in the study by testing instability at mononucleotide repeats, as previously described (37, 38) . Ethics Committee of the Humanitas Clinical and Research Center approved the study, and written informed consent was obtained by the referring physician, at the time of surgery by each patient. Slides were digitized using a computer-aided image analysis system (Olympus DotSlide, Olympus, Italy).
Research. containing low density of CD3+ TILs (Figure 2A, right) . In fact, the density of TLT linearly correlated with the density of dispersed tumor infiltrating CD3+ T cells (R=0.32; P<0.001) (Supplementary Table S2 and Figure 2B ).
Since lymphoid tissue contained PNAd+ high endothelial venules, specialized vessels with a key role in the traffic of T cells (Figure 1D) , we aimed to explain the correlation of TLT and TILs in human CRC, by quantifying the distribution of HEV in colo-rectal cancer specimens. HEV were present mostly in the context of TLT and very rarely found in the surrounding tumor tissue.
Comparison between lymphoid tissue associated to the normal mucosa ( Figure 2C, left) and TLT at the invasive front of the tumor (Figure 2C, right) showed an increased number of HEV associated to lymphoid follicles in the tumor compartment (P<0.05) (Figure 2D) , indicating that the process of lymphoid neogenesis in human CRC includes formation of HEV, which might allow recruitment of T cells.
Density of TLT associates with a better prognosis in CRC patients. We then investigated the clinical significance of TLT in relationship with TILs in a retrospective cohort study. Considering the overall cohort, TLT IRA% at the invasive tumour front ranged from 0% to 23.98%, with a median value of 2.68% (second-third quartiles, 0.75%-5.99%). TLT was present in 276 (78.6%) of 351 tumors and the distribution was skewed towards low values. Distributions of TLT according to the patient histopathological characteristics are described in Supplementary Table S2 . We recorded 84 events of CRC disease relapse (DFS) in 351 stage II and III CRC patients.
Unadjusted univariate analysis showed that high TLT density (≥median) significantly correlated with better outcome (HR 0.62, 95% CI 0.40-0.97; Supplementary Table S3) . Importantly, to control for confounders, we performed multivariate Cox analysis which revealed an interaction between higher densities (≥median) of both TLT and TILs with nodal status in predicting patients relapse (P=0.07 and P=0.03, respectively), which suggests that the ability of TLT and TILs to predict patients relapse may change according to nodal status (Supplementary Table S3) . We therefore performed a subgroup analysis revealing that in patients with node-negative CRC (n=185), a high density of TLT (≥median, 2.68%) and of TILs (≥median, 2.06%) was associated with better prognosis compared to patients with a low density of TLT and TILs (log-rank test, P=0.02 and P=0.02, respectively) ( Figure 3A-B, left) ; conversely, TLT and TIL densities were irrelevant to predict the prognosis of patients with node-positive CRC (n=166) (log-rank test, P=0.46 and P=0.64, respectively) ( Figure 3A-B, right) . Moreover, we further confirmed that the prognostic behaviour of TLT and TILs varies with disease extent in a different analysis, performed with continuous values. Similarly to TILs (Figure 3C, right) , among node-negative CRC patients, TLT density was significantly lower in patients who relapsed (n=26) than in patients with no These results suggest that the prognostic behaviour of TLT is similar to that of TILs and prompted us to test which one was the best prognostic marker. However, since these biomarkers identified overlapping populations, which were mutually dependent in predicting prognosis (data not shown), Figure 3D showed that TLT correlates with TILs density (≥median) only in patients who did not experience relapse (P= 0.001), but not in those who relapsed (P=0.28) (Figure 3D) , thus suggesting that the two biomarkers are coordinated in mediating the antitumor response only among patients with a good prognosis.
Our data have shown that microsatellite instable (MSI) CRC patients had a tendency to better prognosis compared to those with microsatellite stable (MSS) phenotype, although not statistically significant [HR=0.56; 95%CI (0.27-1.16), P=0.12] (Supplementary table S3) . To further address whether the prognostic value of MSI might differ according to the density of TLT, we performed Kaplan Meyer curves with subgroups analyses (Supplementary figure S1) . The analysis showed that MSI CRC was not significantly associated with prognosis in both patients with TLT density low (<median) or high (≥median), (P=0.27, P=0.36, respectively), thus being independent variables in predicting prognosis (Supplementary figure S1) .
Tertiary lymphoid tissue is involved in lymphocyte infiltration in a preclinical model of CRC.
Despite CD3+ T cell density is recognized as a prognostic marker for CRC patients (3, 4) Figure S2D) , consistently with the local induction of TLT in chronically inflamed tissues. To define the association of TLT with T lymphocytes in CRC, we compared CD3+ T cells within TLT of control and AOM/DSS mice ( Figure 4A, left and middle) .
Quantification of the T cell infiltrate indicated that the number of CD3+ T cells in lymphoid tissue
significantly increased in AOM/DSS mice (Figure 4A, right) . Thus, as evidenced by our previous clinical analysis, this result further confirmed in a preclinical model that TLT associates to increased T cell infiltration in CRC.
To test the hypothesis that TLT is actively involved in the recruitment of lymphocytes, we intravenously injected GFP+ splenocytes into control mice and mice subjected to the AOM/DSS Whole mount tissue analysis of TLT in murine colons allowed to visualize a dense network of vessels surrounding TLT, which included CD31+ blood vessels and Lyve-1+ lymphatic vessels ( Figure 4C, left and middle) . Quantification of the volume of vessels draining TLT evidenced a significant increase in AOM/DSS mice compared to control mice (Figure 4C, right) . Among CD31+ vessels, lymphoid tissue contained PNAd+ high endothelial venules ( Figure 4D, left) ; CD3+ T cells were localized inside HEV and in close proximity to the vessel wall (Figure 4D, middle) . The number of PNAd+ HEV within lymphoid tissue of AOM/DSS mice was higher of, compared to control mice (Figure 4D, right) , thus confirming that TLT formation in colon cancer associates to expansion of a vascular network and can sustain lymphocyte recruitment. coordinated in their clinical relevance in early stage human CRC. Thus, TLT assessment should also be considered when the prognostic value of TILs is investigated.
We found that TLT and TILs populations are highly overlapping in their extent and prognostic abilities, since these biomarkers were mutually dependent in predicting patient's prognosis.
However, we provided phenomenological evidence that the antitumour algorithm represented by TLT and TIL densities is coordinated only when identifying CRC who were not relapsing. Thus, it is conceivable to hypothesize that T cell recruitment and the mounting of an efficient T-cell antitumor Overall, the occurrence and modulation of TLT may be particularly significant in the development and the responsiveness of novel immunotherapeutic approaches. In this scenario, we also provided further phenomenological evidence to the idea that nodal invasion is crucial in determining the efficiency and the coordination of adaptive anti-tumor responses (47) .
Nevertheless, the lack of murine models properly reproducing the progression of CRC across its stages of disease might explain at least in part recent failures in translating immunotherapeutic approaches to clinical practice. Therefore, we suggest that TNM stage of disease should be a 
